Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
SEC Accession No. 0001551163-21-000013
Filing Date
2021-04-29
Accepted
2021-04-29 17:24:51
Documents
81
Period of Report
2020-06-30

Document Format Files

Seq Description Document Type Size
1 sgbivedgar8.htm 10-K/A 598209
2 ex211.htm EX-21 2030
3 ex311.htm EX-31 7988
4 ex312.htm EX-31 8089
  Complete submission text file 0001551163-21-000013.txt   2856983

Data Files

Seq Description Document Type Size
5 sgbi-20200630.xml EX-101.INS 392730
6 sgbi-20200630.xsd EX-101.SCH 69624
7 sgbi-20200630_cal.xml EX-101.CAL 28388
8 sgbi-20200630_def.xml EX-101.DEF 97118
9 sgbi-20200630_lab.xml EX-101.LAB 190026
10 sgbi-20200630_pre.xml EX-101.PRE 195913
Mailing Address 352 SOUTH 200 WEST SUITE 3 FARMINGTON UT 84025
Business Address 352 SOUTH 200 WEST SUITE 3 FARMINGTON UT 84025 011 49 (40) 6093120
SANGUI BIOTECH INTERNATIONAL INC (Filer) CIK: 0001104280 (see all company filings)

EIN.: 841330732 | State of Incorp.: CO | Fiscal Year End: 0630
Type: 10-K/A | Act: 34 | File No.: 000-29233 | Film No.: 21872245
SIC: 2834 Pharmaceutical Preparations